High initial burst release of gentamicin formulated as PLGA microspheres implant for treating orthopaedic infection

Antibiotic treatment of orthopaedic infection is complicated by systemic toxicity and the need of effective therapeutic concentration necessary to ensure optimum killing of bacteria. To overcome the problem of systemic toxicity and to achieve a high initial release followed by sustained release of a...

Full description

Bibliographic Details
Main Authors: Harun Ismail, Ahmad Fahmi, Doolaanea, Abd Monem, Awang, Mohamed, Mohamed, Farahidah
Format: Article
Language:English
Published: Academic Sciences 2012
Subjects:
Online Access:http://irep.iium.edu.my/25825/
http://irep.iium.edu.my/25825/
http://irep.iium.edu.my/25825/1/High_burst_release_gentamicin_formulated_as_PLGAmicrospheres.pdf
id iium-25825
recordtype eprints
spelling iium-258252012-09-24T06:12:41Z http://irep.iium.edu.my/25825/ High initial burst release of gentamicin formulated as PLGA microspheres implant for treating orthopaedic infection Harun Ismail, Ahmad Fahmi Doolaanea, Abd Monem Awang, Mohamed Mohamed, Farahidah RS Pharmacy and materia medica Antibiotic treatment of orthopaedic infection is complicated by systemic toxicity and the need of effective therapeutic concentration necessary to ensure optimum killing of bacteria. To overcome the problem of systemic toxicity and to achieve a high initial release followed by sustained release of antibiotics, a new method of delivering gentamicin is attempted by encapsulating gentamicin into PLGA using multiple emulsion, solvent-evaporation method. Gentamicin was first extracted from the microspheres and quantified using ninhydrin assay before the concentration was measured using UV spectrophotometer. Gentamicin efficacy after encapsulation was preserved when CTAB (83.51 ± 1.42%) and low molecular weight (LMW) PLGA (82.38 ± 9.08%) were used as indicated by drug loading efficiency of more than 80% in the disc-diffusion assay. LMW PLGA enabled high burst release (~90%) of gentamicin within the first 10 hours corresponding to zone inhibition of 13.78 ± 0.86 mm, only 30% smaller than the positive control (10 mg/ml gentamicin). The effects of Tg Keywords: Micro particles, Gentamicin; Surfactant, PLGA, Controlled-release and molecular weight rather than surfactant types influence the initial burst release. The in vitro release profile suggests that by having a mixture of various PLGA microspheres in one dosage implant system, the high burst release can be sustained within therapeutic concentration for a prolonged period (> 1 months). This biodegradable delivery system does not entail another surgery to remove the implant hence reducing the high treatment cost usually associated with the non-biodegradable proprietary gentamicin-polymethyl-methacrylate (PMMA) beads currently in use. Academic Sciences 2012-09 Article PeerReviewed application/pdf en http://irep.iium.edu.my/25825/1/High_burst_release_gentamicin_formulated_as_PLGAmicrospheres.pdf Harun Ismail, Ahmad Fahmi and Doolaanea, Abd Monem and Awang, Mohamed and Mohamed, Farahidah (2012) High initial burst release of gentamicin formulated as PLGA microspheres implant for treating orthopaedic infection. International Journal of Pharmacy and Pharmaceutical Sciences, 4 (supp.4). pp. 685-691. ISSN 0975-1491 http://www.ijppsjournal.com/Vol4Suppl4/4819.pdf
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic RS Pharmacy and materia medica
spellingShingle RS Pharmacy and materia medica
Harun Ismail, Ahmad Fahmi
Doolaanea, Abd Monem
Awang, Mohamed
Mohamed, Farahidah
High initial burst release of gentamicin formulated as PLGA microspheres implant for treating orthopaedic infection
description Antibiotic treatment of orthopaedic infection is complicated by systemic toxicity and the need of effective therapeutic concentration necessary to ensure optimum killing of bacteria. To overcome the problem of systemic toxicity and to achieve a high initial release followed by sustained release of antibiotics, a new method of delivering gentamicin is attempted by encapsulating gentamicin into PLGA using multiple emulsion, solvent-evaporation method. Gentamicin was first extracted from the microspheres and quantified using ninhydrin assay before the concentration was measured using UV spectrophotometer. Gentamicin efficacy after encapsulation was preserved when CTAB (83.51 ± 1.42%) and low molecular weight (LMW) PLGA (82.38 ± 9.08%) were used as indicated by drug loading efficiency of more than 80% in the disc-diffusion assay. LMW PLGA enabled high burst release (~90%) of gentamicin within the first 10 hours corresponding to zone inhibition of 13.78 ± 0.86 mm, only 30% smaller than the positive control (10 mg/ml gentamicin). The effects of Tg Keywords: Micro particles, Gentamicin; Surfactant, PLGA, Controlled-release and molecular weight rather than surfactant types influence the initial burst release. The in vitro release profile suggests that by having a mixture of various PLGA microspheres in one dosage implant system, the high burst release can be sustained within therapeutic concentration for a prolonged period (> 1 months). This biodegradable delivery system does not entail another surgery to remove the implant hence reducing the high treatment cost usually associated with the non-biodegradable proprietary gentamicin-polymethyl-methacrylate (PMMA) beads currently in use.
format Article
author Harun Ismail, Ahmad Fahmi
Doolaanea, Abd Monem
Awang, Mohamed
Mohamed, Farahidah
author_facet Harun Ismail, Ahmad Fahmi
Doolaanea, Abd Monem
Awang, Mohamed
Mohamed, Farahidah
author_sort Harun Ismail, Ahmad Fahmi
title High initial burst release of gentamicin formulated as PLGA microspheres implant for treating orthopaedic infection
title_short High initial burst release of gentamicin formulated as PLGA microspheres implant for treating orthopaedic infection
title_full High initial burst release of gentamicin formulated as PLGA microspheres implant for treating orthopaedic infection
title_fullStr High initial burst release of gentamicin formulated as PLGA microspheres implant for treating orthopaedic infection
title_full_unstemmed High initial burst release of gentamicin formulated as PLGA microspheres implant for treating orthopaedic infection
title_sort high initial burst release of gentamicin formulated as plga microspheres implant for treating orthopaedic infection
publisher Academic Sciences
publishDate 2012
url http://irep.iium.edu.my/25825/
http://irep.iium.edu.my/25825/
http://irep.iium.edu.my/25825/1/High_burst_release_gentamicin_formulated_as_PLGAmicrospheres.pdf
first_indexed 2023-09-18T20:38:29Z
last_indexed 2023-09-18T20:38:29Z
_version_ 1777409206246178816